Navigation Links
Memory Pharmaceuticals Reports First Quarter 2008 Financial Results
Date:5/14/2008

>

Net loss $(13,445) $(8,863)

Basic and diluted net loss

per share of common stock $(0.18) $(0.13)

Basic and diluted weighted average number

of shares of common stock outstanding 72,726 70,146

MEMORY PHARMACEUTICALS CORP.

CONDENSED BALANCE SHEETS

(in thousands)

(unaudited)

March 31, December 31,

2008 2007

ASSETS

Cash, cash equivalents and marketable securities $27,493 $38,201

Other current assets 1,359 1,417

Restricted cash 505 505

Deferred financing costs, net 444 519

Property and equipment, net 5,525 5,868

Total assets $35,326 $46,510

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY

Current liabilities (excluding deferred revenue) $11,674 $8,789

Equipment notes payable, less current portion 31 66

Loan payable, less current portion 9,669 10,831

Deferred revenue 17,715 18,051

Other non-current liabilities 495 506

Total liabilities 39,584 38,243

Stockholders' (deficit) equity (4,258) 8,267

Total liabilities and

stockholders' (deficit) equity $35,326 $46,510


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008
2. Memory in artificial atoms
3. Memory Pharmaceuticals Receives Nasdaq Notification
4. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
5. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
6. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
7. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
9. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
10. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
11. ASU researchers improve memory devices using nanotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Wilmington, DE (PRWEB) January 22, 2015 ... the Pistoia Alliance, which helps companies check the legal ... set to expand to China. , As their ... companies are globally adopting software solutions built as a ...
(Date:1/22/2015)... , 22 de enero de 2015  El Dr. ... su llamada a nominaciones para 2015. Este prestigioso premio ... o tiene el potencial para hacer, contribuciones destacadas para ... aceptarán hasta el 15 de marzo de 2015 a ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision ... tools to enable the broad use of genomic, imaging and ... the appointment of Michelle Munson , CEO of Aspera, ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2
... HAVEN, Conn., Aug. 15 VION,PHARMACEUTICALS, INC. (Nasdaq: ... due August 15, 2007 on its 7.75% Convertible Senior ... the Notes is $60,million. The Company paid $2,260,416.67 ... Common Stock. Approximately $2,259,888 was paid in,2,539,200 shares of ...
... Switzerland and OSAKA, Japan, August 16 /PRNewswire-FirstCall/,-- ... specialty,pharmaceutical company with a focus on neuromuscular ... jointly announced,today that the European Medicines Agency ... Authorization Application (MAA) for Santhera,s lead compound,SNT-MC17 ...
... 16 Cancer patients fraught with,flare-ups of pain, ... the form of a new easy-to-use oral drug ... deliver pain medication. Cancer patients frequently experience ... pain is characterized as continuous pain,present for long ...
Cached Biology Technology:Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 2Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes 3European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 2European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 3European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 4European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 5European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera 6Novel Technology Breaks Through Cancer Pain 2
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
(Date:1/22/2015)... , Europe,s most prestigious innovation prize ... present a video retrospective of the most exciting and innovative nominations  ... and Sophie Wilson   A different theme ... Starting on 22 January 2015 on   http://www.epo.org/european-inventor   ...
(Date:12/22/2014)... Inc. (NASDAQ: NXTD and NXTDW) ("NXT-ID" or ... mobile commerce market, announces it has retained famous pickpocket, entertainer ... International CES debut of the Wocket™ biometric smart wallet.  ... NXT-ID booth January 6th and 7 th , 2015, demonstrating ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... The American Association for Dental Research (AADR) has ... W. Chilton Fellowship in Clinical Research recipient. He will ... in Washington, DC, March 3, 2010. Currently, Dawson ... of the Delta Dental of Kentucky Clinical Research Center, ...
... Baos, Philippines: In the last fifty years, the Philippines has more ... has increased only about 2.3 times. Despite being criticized ... world,s biggest rice importer, the Philippines has actually done remarkably well ... 1960* to 3.59 tons per hectare in 2009**. In ...
... Brain researcher Hiroshi Kawabe has discovered the workings of a ... allows nerve cells in the brain to grow and form ... controls the destruction of protein components has an unexpected function ... and thus ensures that nerve cells can form the tree-like ...
Cached Biology News:The Philippines triples its rice yield 2How nerve cells grow 2
... Interaction Kit provides an extremely fast ... isolate intact protein complexes. Unlike other ... multiple purification steps, this system takes ... Superflow Column for fast protein purification ...
poliovirus receptor-related 2 (herpesvirus entry mediator B), mRNA...
...
cysteine and glycine-rich protein 2,...
Biology Products: